ELVN Enliven Therapeutics, Inc.
Healthcare$41.56+0.00%OpenMarket Cap: $2.53B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$69.50
Target (Median)
$69.50
Target Range
$59.00 - $80.00
Upside from current price: 67.2%
Rating Distribution
0 Strong Buy9 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-08 | Goldman Sachs | maintain | Buy | Buy |
| 2026-03-26 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-25 | Mizuho | maintain | Outperform | Outperform |
| 2025-07-02 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-06-16 | Baird | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-2.38 | $10.0K | 3 |
| Sun Dec 31 | $-3.04 | $16.7K | 6 |
| Mon Dec 31 | $-3.16 | $69.5M | 4 |
| Tue Dec 31 | $-0.85 | $333.1M | 2 |